The Microbiome and Metabolome of the Gut of Children with Sepsis and Septic Shock
BACKGROUND: There is limited understanding of alteration of gut microbiota and metabolome in children with sepsis/septic shock.
METHODS: In this prospective observational study carried out in a pediatric intensive care unit of a tertiary care center from 2020 to 2022, patients aged <17 years with sepsis/septic shock and healthy children (HC) were enrolled. We characterized the gut bacterial compositions by metagenome sequencing and metabolomes by untargeted gas chromatography-mass spectrometry. The primary outcome was to compare the gut microbiota and metabolome of children with sepsis/septic shock with that of HC. The Firmicutes/Bacteroidetes (F/B) ratio was compared between children with sepsis/septic shock and HC. Key secondary outcomes were to evaluate association of factors associated with a low F/B ratio in children with sepsis/septic shock.
RESULTS: A total of 40 children (63% boys) (15 children with sepsis and septic shock and 10 healthy children) with a median (IQR) age of 5.5 (1.5, 10) years were enrolled. In the fecal microbiota, the α-diversity index including Shannon and Simpson indices of the sepsis/septic shock groups was significantly lower than that of the HC. The samples lacked beneficial Bifidobacterium spp. and were dominated by Bacteroides, Enterobacteriaceae, and Enterococcaceae. There was reduction in short-chain fatty acids (SCFAs) in patients with sepsis/septic shock as compared to healthy children. A lower F/B ratio (≤1.57) of the gut microbiota discriminated well between children with sepsis/septic shock and HC. Factors associated with lower F/B ratio were male gender, clinical GI dysfunction, elevated inflammatory markers, and higher organ failure scores.
CONCLUSION: There were significant alterations in the gut microbiota and metabolome in children with sepsis/septic shock as compared to healthy children. Larger study is needed to confirm these exploratory findings and develop potential therapeutic targets that will improve outcomes in children with sepsis/septic shock.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - year:2023 |
|---|---|
| Enthalten in: |
Journal of intensive care medicine - (2023) vom: 10. Dez., Seite 8850666231216361 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Sankar, Jhuma [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Gastrointestinal dysfunction |
|---|
| Anmerkungen: |
Date Revised 11.12.2023 published: Print-Electronic Citation Status Publisher |
|---|
| doi: |
10.1177/08850666231216361 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM365639710 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM365639710 | ||
| 003 | DE-627 | ||
| 005 | 20231229123258.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1177/08850666231216361 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1227.xml |
| 035 | |a (DE-627)NLM365639710 | ||
| 035 | |a (NLM)38073164 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Sankar, Jhuma |e verfasserin |4 aut | |
| 245 | 1 | 4 | |a The Microbiome and Metabolome of the Gut of Children with Sepsis and Septic Shock |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 11.12.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status Publisher | ||
| 520 | |a BACKGROUND: There is limited understanding of alteration of gut microbiota and metabolome in children with sepsis/septic shock | ||
| 520 | |a METHODS: In this prospective observational study carried out in a pediatric intensive care unit of a tertiary care center from 2020 to 2022, patients aged <17 years with sepsis/septic shock and healthy children (HC) were enrolled. We characterized the gut bacterial compositions by metagenome sequencing and metabolomes by untargeted gas chromatography-mass spectrometry. The primary outcome was to compare the gut microbiota and metabolome of children with sepsis/septic shock with that of HC. The Firmicutes/Bacteroidetes (F/B) ratio was compared between children with sepsis/septic shock and HC. Key secondary outcomes were to evaluate association of factors associated with a low F/B ratio in children with sepsis/septic shock | ||
| 520 | |a RESULTS: A total of 40 children (63% boys) (15 children with sepsis and septic shock and 10 healthy children) with a median (IQR) age of 5.5 (1.5, 10) years were enrolled. In the fecal microbiota, the α-diversity index including Shannon and Simpson indices of the sepsis/septic shock groups was significantly lower than that of the HC. The samples lacked beneficial Bifidobacterium spp. and were dominated by Bacteroides, Enterobacteriaceae, and Enterococcaceae. There was reduction in short-chain fatty acids (SCFAs) in patients with sepsis/septic shock as compared to healthy children. A lower F/B ratio (≤1.57) of the gut microbiota discriminated well between children with sepsis/septic shock and HC. Factors associated with lower F/B ratio were male gender, clinical GI dysfunction, elevated inflammatory markers, and higher organ failure scores | ||
| 520 | |a CONCLUSION: There were significant alterations in the gut microbiota and metabolome in children with sepsis/septic shock as compared to healthy children. Larger study is needed to confirm these exploratory findings and develop potential therapeutic targets that will improve outcomes in children with sepsis/septic shock | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a gastrointestinal dysfunction | |
| 650 | 4 | |a gut microbiota | |
| 650 | 4 | |a metabolome | |
| 650 | 4 | |a sepsis | |
| 650 | 4 | |a septic shock | |
| 650 | 4 | |a short-chain fatty acids | |
| 650 | 4 | |a taxa | |
| 700 | 1 | |a Thakral, Vaishali |e verfasserin |4 aut | |
| 700 | 1 | |a Bharadwaj, Kanchan |e verfasserin |4 aut | |
| 700 | 1 | |a Agarwal, Sheetal |e verfasserin |4 aut | |
| 700 | 1 | |a Kabra, Sushil Kumar |e verfasserin |4 aut | |
| 700 | 1 | |a Lodha, Rakesh |e verfasserin |4 aut | |
| 700 | 1 | |a Rathore, Sumit |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of intensive care medicine |d 1991 |g (2023) vom: 10. Dez., Seite 8850666231216361 |w (DE-627)NLM08584439X |x 1525-1489 |7 nnns |
| 773 | 1 | 8 | |g year:2023 |g day:10 |g month:12 |g pages:8850666231216361 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1177/08850666231216361 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |j 2023 |b 10 |c 12 |h 8850666231216361 | ||